Possible use of erythrocyte antioxidant enzymes as markers of the course of disease in patients with hemoblastoses

A. O. Kumerova, V. I. Petukhov, Andrejs Šķesters, A. A. Silova, A. G. Letse

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Blood and erythrocytes of 50 healthy volunteers and 105 patients with different forms of hemoblastoses were investigated. 54 patients had acute phase, 51 patients--remission stage of disease. Essential differences in the activity of antioxidant enzymes (SOD, CAT, GSH-Px) were detected and compared with content of MDA and degree of anaemia. Acute phase had more significantly alteration of antioxidant defence: diverse changes of the activity of SOD and CAT, significantly inhibition of GSH-Px, the high level of MDA and increased degree of anaemia.

Translated title of the contributionPossible use of erythrocyte antioxidant enzymes as markers of the course of disease in patients with hemoblastoses
Original languageRussian
Pages (from-to)144-147
Number of pages4
JournalVoprosy Meditsinskoi Khimii
Volume42
Issue number2
Publication statusPublished - Apr 1996

Field of Science*

  • 3.1 Basic medicine

Publication Type*

  • 1.1. Scientific article indexed in Web of Science and/or Scopus database

Fingerprint

Dive into the research topics of 'Possible use of erythrocyte antioxidant enzymes as markers of the course of disease in patients with hemoblastoses'. Together they form a unique fingerprint.

Cite this